## Epstein-Barr virus-induced IgE production in limiting dilution cultures of normal human B cells* The induction of in vitro IgE production in human B cells from normal, nonatopic donors has been difficult and somewhat controversial. We report that IgE production is consistently observed in limit
Production of hepatitis b e antibody in epstein-barr virus-induced b lymphocyte cell lines
✍ Scribed by Dr. Yumiko Furuya; Masayasu Inoue; Yoshiya Yoshida; Namiko Yoshihara; Mitsuru Fakada
- Publisher
- John Wiley and Sons
- Year
- 1982
- Tongue
- English
- Weight
- 492 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
B lymphocytes separated from anti‐HBe‐positive donors were established as lymphoblastoid cell lines by infection with EBV, but anti‐HBe in the culture supernatant from such lymphoblastoid cell lines could not be detected. The lymphoblastoid cell lines were rosetted with HBe antigen‐coupled SRBC to prepare cells for the production of specific anti‐HBe. Antibody activity in the culture supernatant against rosette forming cells was detected by RIA, ID, and R‐PHI tests during the first 1 to 4 wk, but not after 5 wk. The activity in the supernatant was not destroyed by treatment with 2‐mercaptoethanol, indicating that the antibody might be IgG.
📜 SIMILAR VOLUMES
## Abstract Hepatitis C virus (HCV) infection is associated with lymphoproliferative disorders. HCV infection of B cells is a predictive factor for lymphoproliferative disorders in patients with chronic hepatitis C, although its molecular mechanisms remain unknown. Epstein–Barr virus (EBV) is a B c
A method of producing human monoclonal antibody by combining somatic cell hybridization technology with the capability of Epstein-Barr virus (EBV) to transform human B lymphocytes is described. Peripheral blood lymphocytes from a donor with positive tuberculin skin test reaction were transformed by
We examined the patterns of viral gene expression in acute infectious mononucleosis (IM) patients and the clonality of the directly growing EBV-carrying cell lines. Both low- and high-density EBV-carrying B cells obtained from the patients' tonsils expressed EBNA1, EBNA2 and LMP1. Like LCLs and immu